(Montreal) A new highly secure laboratory has just opened in the midst of a pandemic in Quebec: the INRS on Wednesday inaugurated state-of-the-art facilities that make it possible to handle and carry out research on dangerous pathogens, such as the West Nile virus and the one causing COVID-19.
Posted on March 10, 2021 at 2:24 p.m.
–
–
This level 3 containment laboratory, commonly called the “NC3”, is a kind of “sealed box” located at the Center Armand-Frappier Santé Biotechnologie (AFSB) of the National Scientific Research Institute (INRS), in Laval. .
It will make it possible to perform in vitro experiments on several high-risk pathogens under infectious conditions similar to those of the diseases they cause – while being safe.
Without this high-security laboratory – all the air in and out of it is filtered, preventing aerosols that may contain viruses from escaping – no way for researchers to do their work in such close to real conditions. .
The laboratory was made possible thanks to an investment of nearly $ 300,000 from INRS.
It will do a lot of things, including researching potential treatments for COVID-19, or trying to determine why some variants are more contagious than others.
Among the work that will be carried out there, the INRS highlighted those relating to the therapeutic efficacy of a bank of molecules for the treatment of COVID-19 and those that will study the impact of the SARS-CoV-2 virus – that of causing COVID-19 – on the functions of the placenta.
“To react quickly in times of pandemic, we must work upstream,” said specialist in molecular virology Laurent Chatel-Chaix, director of this NC3 laboratory and also professor at INRS.
This most recent level 3 containment laboratory inaugurated in Quebec is located in the heart of the biotechnology city of Laval: it will make possible international collaborations and also with private companies, underlined Claude Guertin, director of the AFSB center.
“Access to a containment level 3 laboratory accredited by the Public Health Agency of Canada is one way to remain leaders in fields such as virology and immunology. ”
–